metabolic associated fatty liver disease (MASLD) and 2 diabetes mellitus
Conditions
Interventions
Sponsors
The Affiliated Hospital of Qingdao University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Patients aged >= 18 and = 3 months 4. Voluntarily participated in this study and signed the informed consent form
Exclusion criteria
Exclusion criteria: 1. Patients with specific liver diseases that can induce fatty liver, such as alcoholic liver disease, viral liver disease, drug-induced liver disease (except for taking hypoglycemic drugs), autoimmune hepatitis, Wilson's disease, etc. 2. Pregnant patients, and those complicated with severe systemic diseases such as acute or chronic renal failure; 3. Patients with incomplete clinical data and examination results that cannot meet the needs of research analysis; 4. Subjects who voluntarily withdraw from this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ultrasound Derived Fat Fraction; | — |
Secondary
| Measure | Time frame |
|---|---|
| Point Shear Wave Elastography; | — |
Countries
China
Contacts
Public ContactCheng Zhao; Danni Jiang
The Affiliated Hospital of Qingdao University
Outcome results
None listed